Advanced search
Publication Cover
Brain Injury Volume 14, 2000 - Issue 10
Submit an article Journal homepage
114
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Naltrexone: effects on motor function, speech, and activities of daily living in a patient with traumatic brain injury

Ronald Calvanio, David T. Burke, Hyun Jung Kim, Jie Cheng, Paige Lepak, Julie Leonard, Melissa A. Dwyer, Virkram Gavande Spaulding Rehabilitation Hospital; University of Texas
Pages 933-942 | Published online: 03 Jul 2009

References

  • WHYTE, J., HAK T., SCHUSTER, K. et al.: Effects of methylphenidate on attentional function after traumatic brain injury. A randomized, placebo-controlled trial. American Journal of Physical Medicine & Rehabilitation, 76: 440–450, 1997.
  • WALKER-BATSON D., SMITH, P., CURTIS, S. et al.: Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence. Stroke, 26: 2254–2259, 1995.
  • KARLI, D. C., BURKE, D. T., KIM, H. J. et al.: Effects of dopaminergic combination therapy for frontal lobe dysfunction in traumatic brain injury rehabilitation. Brain Injury, 13: 63–68, 1999.
  • ZAFONTE, R. D., WATANABE, T. and MANN N. R.: Amantadine: a potential treatment for the minimally conscious state. Brain Injury, 12: 617–621, 1998.
  • MCDOWELL, S., WHYTE, J. and D'E SPORT°, M.: Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. Brain, 121: 1155–1164, 1998.
  • KRAUS, M. F. and MAKI, P.: The combined use of amantadine and 1-dopa/carbidopa in the treatment of chronic brain injury. Brain Injury, 11: 455–460, 1997.
  • POWELL, J. H., AL-ADAWI, S., MORGAN J. et al.: Motivational deficits after brain injury: effects of bromocriptine in 11 patients. Journal of Neurology, Neurosurgery & Psychiatry, 60: 416–421, 1996.
  • EDBY, K., LARSSON J., EEK, M. et al.: Amantadine treatment of a patient with anoxic brain injury. Childs Nervous System, 11: 607–609, 1995.
  • DOBKIN B. H. and HANLON R.: Dopamine agonist treatment of antegrade amnesia from a mediobasal forebrain injury. Annals of Neurology, 33: 313–316, 1993.
  • GENTILE, N. T. and MCINTOSH, T. K.: Antagonists of excitatory amino acids and endogenous opioid peptides in the treatment of experimental central nervous system injury. Annals of Emergency Medicine, 22: 1028–1034, 1993.
  • MCINTOSH, T. K., HEAD, V. A. and FADEN A. I.: Alterations in regional concentrations of endo-genous opioids following traumatic brain injury in the cat. Brain Research, 425: 225–233, 1987.
  • MCINTOSH, T. K., HAYES, R. L., DEWITT, D. S. et al.: Endogenous opioids may mediate secondary damage after experimental brain injury. American Journal of Physiology, 253: E565–E574, 1987.
  • MCINTOSH, T. K., FERNYAK, S., HAYES, R. L. et al.: Beneficial effect of the nonselective opiate antagonist naloxone hydrochloride and the thyrotropin-releasing hormone (TRH) analog YM-14673 on long-term neurobehavioral outcome following experimental brain injury in the rat. Journal of Neurotrauma, 10: 373–384, 1993.
  • ARMSTEAD, W. M. and KURTH, C. D.: The role of opioids in newborn pig fluid percussion brain injury. Brain Research, 660: 19–26, 1994.
  • TENNANT, F. S. JR and WILD, J.: Naltrexone treatment for postconcussional syndrome. American Journal of Psychiatry, 144: 813–814, 1987.
  • SELIGER, G. M., LICHTIVIAN S. W. and HORNSTEIN, A.: Naltrexone improves severe posttraumatic abulia. Journal of Neurologic Rehabilitation, 12: 29–31, 1999.
  • MELEGFR, A., BURKE, D., DILLON K. et al.: Effect of naltrexone on significant posttraumatic abulia and functional independence measure profile. American Journal of Physical Medicine and Rehabilitation, 78: 190, 1999.
  • HAYES, R. L., LYETH, B. G., JENKINS, L. W. et al.: Possible protective effect of endogenous opioids in traumatic brain injury. Journal of Neurosurgery, 72: 252–261, 1990.
  • LYETH, B. G. and HAYES, R. L.: Cholinergic and opioid mediation of traumatic brain injury [Review] [94 ref]. Journal of Neurotrauma, 9\(Suppl 2): S463-S474, 1992.
  • MCNICHOLAS, L. F. and MARTIN W. R.: New and experimental therapeutic roles for naloxone and related opioid antagonists [Review] [127 ref.] Drugs, 27: 81–93, 1984.
  • VINK, R., MCINTOSH, T. K., RHOMHANYI, R. et al.: Opiate antagonist nalmefene improves intracellular free Mg2+, bioenergetic state, and neurologic outcome following traumatic brain injury in rats. Journal of Neuroscience, 10(11): 3524–3530, 1990.
  • BACKMAN, C. L. andHARRI S. R.: Case studies, single-subject research, and N of 1 randomized trails: comparisons and contrasts. American Journal of Physical Medicine & Rehabilitation, 78: 170–176, 1999.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.